CURRICULUM VITAE

FRANCIS W. PRICE, JR., M.D.

Date and Place of Birth:         February 4, 1951
Indianapolis, Indiana

Education:
B.S. ‑ 1973    University of Notre Dame, South Bend, IN

M.D. ‑ 1977    Indiana University, Indianapolis, IN

Postgraduate Education: 
1977 ‑ 1978       Internship
                        Methodist Hospital, Indianapolis, IN

1978 ‑ 1981        Resident in Ophthalmology
                        Indiana University, Indianapolis, IN

1981 ‑ 1982       Fellowship - Cornea and External Disease
                        Tulane University, New Orleans, LA

Employment

1983 - present    President, Price Vision Group   
9002 N Meridian Street, Suite 100
Indianapolis, IN  46260
                                   1988 – present    Founder and President of the Board,
                                                            Cornea Research Foundation of America

Board Certification:      
1982 ‑ Ophthalmology

Honorary Societies:       
1973 ‑ Phi Beta Kappa 
1977 ‑ Alpha Omega Alpha

Licensed:
Indiana 1977
Hawaii 1986


Professional Committees and Organizations:

    • Indiana State Medical Association ‑ Sub‑Commission on Insurance                1981 to present
    • Marion County Medical Society ‑ Professional Affairs Committee                  1981‑1988
    • Indiana Academy of Ophthalmology ‑ President                                            1989/1991
    • Indiana Academy of Ophthalmology Eye Bank Committee - Chairman           1992-Present
    • Community Hospitals Indianapolis ‑ Ophthalmology Dept. Chairman               1987-1989
    • Eye Bank Association of America
    • Paton Society
    • American Academy of Ophthalmology
    • American Society of Cataract and Refractive Surgery
    • International Society of Refractive Surgery ‑ Director                                    1989/1991
    • The Association for Research in Vision and Ophthalmology                           1993-Present

    Publications:

    1. Trespalacios R, Price MO, Jordan CS, Price FW. Changes in Intraocular Pressure Measurements After Descemet’s Stripping With Endothelial Keratoplasty (DSEK). Journal of Cataract and Refractive Surgery 2007 in submission.
    2. Price MO, Jordan CS, Trespalacios R, Moore G, Price FW. Graft Rejection Episodes after Descemet’s Stripping with Endothelial Keratoplasty: Incidence, Risk Factors and Clinical Characteristics. Ophthalmology 2007, in submission.
    3. Vajaranant TS, Price MO, Price FW, Wilensky JT, Viana M, Edward DP. Intraocular pressure measurement following DSEK; Does IOP measurement technique matter? Am J Ophthalmol 2007, in submission
    4. Price FW, Price MO. Is it worthwhile to combine penetrating keratoplasty with glaucoma drainage implants? Cornea 2007 in press.
    5. Price FW, Price, MO. Adult keratoplasty: has the prognosis improved in the last 25 years? Ophthalmology International, 2007, in press.
    6. Baig K, Price MO, Price FW. Descemet’s stripping with endothelial keratoplasty. US Ophthalmic Review 2007, in press.
    7. Hainline BC, Price MO, Price FW, Choi DM. Central Flap Necrosis after LASIK.(reply) Journal of Refractive Surgery 2007 in press.
    8. Price FW, Price MO. Femtosecond Laser Shaped Penetrating Keratoplasty: One-year Results Utilizing a Top-Hat Configuration. Am J Ophthalmol 2007 Nov 29 [ePub ahead of print]. http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=ShowDetailView&TermToSearch=18061133&ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
    9. Price MO, Price FW. Endothelial cell density after Descemet’s stripping endothelial keratoplasty: influencing factors and 2-year trend. Ophthalmology. 2007 Sep 13; [Epub ahead of print]. http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=ShowDetailView&TermToSearch=17868873&ordinalpos=3&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
    10. Price FW.  Using a “Small Bubble Technique” helps “Big Bubble Technique”. British Journal of Ophthalmology, 2007; 91:1260-1.

    http://bjo.bmj.com/cgi/content/extract/91/10/1260?maxtoshow=&HITS=10&hits=10&RESULTFORMAT=&author1=Price&andorexactfulltext=and&searchid=1&FIRSTINDEX=0&sortspec=relevance&volume=91&firstpage=1260&resourcetype=HWCIT

    1. Allan B, Terry MA, Price FW, Price MO, Griffin N, Claesson M. Corneal transplant rejection rate and severity after endothelial keratoplasty. Cornea 2007; 26:1039-42. http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=ShowDetailView&TermToSearch=17893530&ordinalpos=3&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
    2. Price FW. Re: Central Toxic Keratopathy: Description of a Syndrome in Laser Refractive Surgery. American Journal of Ophthalmology, 2007; 144:331-2.
    3. Price MO, Price FW. Descemet’s stripping endothelial keratoplasty.  Current Opinion in Ophthalmology 2007; 18:290-4. http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=ShowDetailView&TermToSearch=17568204&ordinalpos=5&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
    4. Price MO, Price FW. Descemet’s stripping with endothelial keratoplasty for treatment of iridocorneal endothelial syndrome. Cornea 2007;26:493-497. http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=ShowDetailView&TermToSearch=17457204&ordinalpos=6&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
    5. Hainline BC, Choi DM, Price MO, Price FW. Central flap necrosis after laser in situ keratomileusis with microkeratome- and femtosecond laser-created flaps.  Journal of Refractive Surgery,2007;23:233-242. http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=ShowDetailView&TermToSearch=17385288&ordinalpos=7&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
    6. Price MO, Price FW, Trespalacios R. Endothelial keratoplasty technique for aniridic aphakic eyes.  J Cataract and Refract Surg 2007; 33:376-379. http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=ShowDetailView&TermToSearch=17321384&ordinalpos=8&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
    7. Lord RK, Price FW, Price MO, Werner L, Mamalis N. Histology of Posterior Lamellar Keratoplasty (PLK) after failure from Scarring Secondary to Herpes Simplex Keratitis. Cornea 2006;25:1093-1096.  http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=ShowDetailView&TermToSearch=17133061&ordinalpos=9&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
    8. Price FW, Price MO. A non-surgical treatment for donor dislocation after Descemet's stripping endothelial keratoplasty (DSEK). Cornea 2006;25:991.
    9. Romaniv N, Price MO, Price FW, Mamalis N. Donor Descemet’s membrane detachment after endothelial keratoplasty. Cornea 2006;25:943-947. http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=ShowDetailView&TermToSearch=17102672&ordinalpos=11&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
    10. Price FW, Price MO.  Endothelial keratoplasty to restore clarity to a failed penetrating graft. Cornea, 2006;25:895-899. http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=ShowDetailView&TermToSearch=17102663&ordinalpos=12&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
    11. Price MO, Price FW. Descemet’s stripping with endothelial keratoplasty: comparative outcomes with microkeratome- and manually-dissected donor tissue.  Ophthalmology, 2006; 113:1936-1942. http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=ShowDetailView&TermToSearch=16935344&ordinalpos=13&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum

     

      • Price MO, Price FW.  Efficacy of topical cyclosporine 0.05% for prevention of cornea transplant rejection episodes.  Ophthalmology 2006;113:1785-90. http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=ShowDetailView&TermToSearch=16884779&ordinalpos=14&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
      • Price FW, Price MO.  Descemet’s stripping with endothelial keratoplasty (DSEK) in 200 eyes:  Early challenges and techniques to enhance donor adherence.  Journal of Cataract & Refractive Surgery, 2006;32:411-418. http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=ShowDetailView&TermToSearch=16631048&ordinalpos=15&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
      • Price MO, Price FW, Maclellan D.  Effect of gatifloxacin 0.3% and moxifloxacin 0.5% ophthalmic solutions on human corneal epithelium following 2 dosing regimens.  Journal of Cataract & Refractive Surgery, 2005; 31:2137-2141. http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=ShowDetailView&TermToSearch=16412928&ordinalpos=16&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
      • Price FW, Price MO. Descemet’s stripping with endothelial keratoplasty in 50 eyes: a refractive neutral corneal transplant. Journal of Refractive Surgery, 2005; 21:339-345. http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=ShowDetailView&TermToSearch=16128330&ordinalpos=17&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
      • Price MO, Price FW, Werner L, Berlie C, Mamalis N.  Late dislocation of scleral-sutured posterior chamber intraocular lenses.  Journal of Cataract & Refractive Surgery, 2005,31:1321-1326. http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=ShowDetailView&TermToSearch=16105601&ordinalpos=18&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
      • Price MO, Quillin C, Price FW.  Effect of gatifloxacin ophthalmic solution 0.3% on aqueous humor Gatifloxacin concentrations and corneal endothelial cell density in normal subjects and in cataract surgery patients.  Current Eye Research, 2005; 30:563-567. http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=ShowDetailView&TermToSearch=16020290&ordinalpos=19&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
      • Price FW. Corneal transplantation as a refractive surgical procedure. Journal of Refractive Surgery, 2005;21:216-217. http://www.journalofrefractivesurgery.com/showAbst.asp?thing=10502
      • Price FW. Pressure-induced interface keratitis: a late complication following LASIK.
        Cornea 2005;4:505; author reply 505.
      • Price FW. Fixed dilated pupil (Urrets-Zavalia syndrome) in corneal dystrophies.
        Cornea. 2005;4:363; author reply 363.
      • Price, FW, Mackool RJ, Miller KM, Koch P, Oetting TA, Johnson T.  Interim results of the United States investigational device study of the Ophtec capsular tension ring.  Ophthalmology, 2005;112:460-465. http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=ShowDetailView&TermToSearch=15745774&ordinalpos=23&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
      • Price MO, Price FW. Efficacy of ketorolac tromethamine 0.4% for control of pain or discomfort associated with cataract surgery.  Current Medical Research and Opinion,2004;20:2015-2019. http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=ShowDetailView&TermToSearch=15701218&ordinalpos=24&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
      • Price MO, Price FW, Chang DF, Kelley KA, Olson MD, Miller KM.  OPHTEC Iris Reconstruction Lens U.S. Clinical Trial Phase I.  Ophthalmology, 2004;111:1847-52. http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=ShowDetailView&TermToSearch=15465545&ordinalpos=25&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
      • Riddle HK, Price MO, Price FW.  Topical anesthesia for penetrating keratoplasty.  Cornea, 2004;23:712-714. http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=ShowDetailView&TermToSearch=15448498&ordinalpos=26&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
      • Bowers PJ, Zeldes SS, Price FW, McManis CL, Price MO.  Outcomes of laser in situ keratomileusis in a refractive surgery fellowship program.  J Refractive Surgery, 2004;20:265-9. http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=ShowDetailView&TermToSearch=15188905&ordinalpos=27&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
      • Price MO, Price FW.  Cataract progression and treatment after posterior lamellar keratoplasty. J Cataract and Refract Surg, 2004;30:1310-5. http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=ShowDetailView&TermToSearch=15177609&ordinalpos=28&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
      • Steinemann TL, Pinninti U, Szczotka LB, Eiferman RA, Price FW.  Ocular complications associated with the use of cosmetic contact lenses from unlicensed vendors.  Eye Contact Lens.  2003 Oct;29(4):196-200. http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=ShowDetailView&TermToSearch=14555891&ordinalpos=29&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
      • Thompson RW, Choi DM, Price MO, Price FW.  Noncontact optical coherence tomography for measurement of corneal flap and residual stromal bed thickness after laser in situ keratomileusis.  J Refractive Surgery, 2003, 19:507-515.
      • Price MO, Thompson RW, Price FW.  Risk factors for various causes of failure in initial corneal grafts.  Archives of Ophthalmology, 2003;121:1087-1092.
      • Bowers P, Price MO, Zeldes S, Price FW.  Superficial keratectomy with Mitomycin C for treatment of Salzmann’s nodules.  J Cataract and Refract Surg, 2003; 29(7):1302-6.
      • Thompson RW, Price MO, Bowers PJ, Price FW.  Long-term graft survival after penetrating keratoplasty.  Ophthalmology, 2003; 110(7):1396-1402.
      • Parker DS, Price FW. Suture fixation of a posterior chamber lens in anticoagulated patients. J Cataract Refract Surg, 2003; 29:949-954.
      • Price FW, Dobbins K, Zeh WG.  Penetration of topically administered ofloxacin and trimethopriminto aqueous humor. J Ocul Pharmacol Ther, 2002; 18:445-53.
      • Thompson RW, Choi DM, Price FW.  Clear lens replacement surgery.   International Ophthalmology Clinics, 2002; 42: 131-152.
      • Price FW. Corneal endothelial damage after trabeculectomy with mitomycin C in two patients with glaucoma with cornea guttata. Cornea. 2002 Oct;21(7):733.
      • Choi DM, Thompson RW, Price FW.  Incisional refractive surgery.  Current Opinion in Ophthalmology 2002; 13:237-241.
      • Price FW. Topical corticosteroids after keratorefractive surgery. J Cataract Refract Surg. 2002 Aug;28(8):1307; author reply 1307-8.
      • Price, FW, Ziemba, SL.  Placement of a collagen glaucoma drainage device to control intraocular pressure and chronic iritis secondary to juvenile rheumatic arthritis.  Ophthalmic Surgery and Lasers, 2002;3:233-36.
      • Price FW, Price MO, Zeh WG, Dobbins K. Pain reduction after LASIK with Ketorolac Tromethamine Ophthalmic Solution 0.5%:  a randomized, double-masked placebo-controlled trial.  J Refract Surg, 2002 Mar-Apr; 18(2):140-4.
      • Price FW, Willes L, Ries J, Lyng A, Price M. A prospective, randomized comparison of the use versus non-use of topical corticosteroids after laser in situ keratomileusis (LASIK). Ophthalmology, 2001 Jul; 108(7):1236-44;discussion 1244-5.
      • Price FW, Zeh WG. Viscoelastic material as an adjunct to dissections and to treat micro-perforations during non-penetrating filtering surgery. J Cataract Refract Surg, 2001 Apr; 27(4):639-641.
      • Dobbins K, Price FW, Whitson WE.  Trends in the Indications for Penetrating Keratoplasty in the Midwestern United States.  Cornea 2000 Nov;19(6):813-816.
      • Price FW. New pieces for the puzzle:  nonsteroidal anti-inflammatory drugs and corneal ulcers. Guest Editorial J Cataract Refract Surg. 2000 Sep;26:1263-65.
      • Zeh WG, Price FW. Iris fixation of posterior chamber intraocular lenses. J Cataract Refract Surg, 2000 Jul;26(7):1028-34.
      • Price FW, Koller DL, Price MO. Central corneal pachymetry in patients undergoing laser in situ keratomileusis. Ophthalmology 1999 Nov;106(11):2216-2220.
      • Riddle HK, Parker DAS, Price FW. Management of post keratoplasty astigmatism. Current Opinion in Ophthalmology 1998 Aug;9(IV):15-28.
      • Price FW Jr., Belin MW, Nordan LT, McDonnell PJ, Pop M. Epithelial haze, punctate keratopathy, and induced hyperopia after photorefractive keratectomy for myopia.  J Refract Surg. 1999 May-June;15(3):384-7.
      • Faktorovich EG, Maloney RK, Price FW, ARC-T Study Group. Effect of astigmatic keratotomy on spherical equivalent: results of the astigmatism reduction clinical trial. American Journal of Ophthalmology 1999 Mar;127(3):260-9.
      • Loden JC, Price FW Jr.  Price graft-over-host technique to manage positive pressure during penetrating keratoplasty.  J Cataract Refract Surg. 1998 Jun;24(6):736-8.
      • Price FW, Parker DA. Horizontal corneal diameter and its implications for implanting sulcus-fixated lenses.J Cataract Refract Surg. 1997 Oct;23(8):1131-2.
      • Price FW, Whitson WE, Gonzales JS, Johns SK. Corneal tissue levels of topically applied ofloxacin. J Cataract Refract Surg 1997;23:898-902
      • Price FW, Green RB, Marks RG, Gonzales J, Arc-T Study Group. Arcuate transverse keratotomy for astigmatism followed by subsequent radial or transverse keratotomy. J Refract Surg 1996;12:68-76.
      • Price FW. Central Islands of corneal steepening after automated lamellar keratoplasty for myopia.  J Refract Surg 1996;12:36-41.
      • Price FW, Whitson WE, Gonzales JS, Gonzales CR, Smith J. Automated lamellar keratomileusis in situ for myopia.  J Refract Surg 1996;12:29-35.
      • Price FW, Whitson WE, Johns SK, Gonzales JS.  Risk factors for corneal graft failure.  J Refract Surg 1996;12:133-146.
      • Steinert RF, Storie B, Smith P, McDonald MB, van Rij G, Bores LD, Colin JP, Durrie DS, Kelley C, Price FW, Rostron C, Waring III GO, Nordan LT. Hydrogel intracorneal lenses in aphakic eyes. Arch Ophthalmol 1996:114:135-141.
      • Price FW, Hanna SI. Bilateral penetrating autokeratoplasty. J Refract Surg 1995;11:   494-496.
      • Price FW, Wellemeyer ML.  Transscleral fixation of posterior chamber intraocular lenses. J Cataract Refract Surg 1995;20:567-573.
      • Price FW, Green RB, Marks RG, Gonzalas JS, Arc-T Study Group. Astigmatism reduction clinical trial: A Multi-Center prospective evaluation of the predictability of arcuate keratotomy.  Arch Ophthalmol 1995;113:277-282.
      • Price FW, Whitson WE, Collins KS, Gonzales JS.  Corneal tissue levels of topically applied Ciprofloxacin. Cornea 14(2);152-156,1995.
      • Price FW, Wellemeyer ML.Long-term results of Molteno implants. Ophthalmic Surg 1995;26(2):1-6.
      • Price FW, Whitson WE, Ahad KA, Tavakkoli H.  Suprachoroidal hemorrhage in penetrating keratoplasty. Ophthalmic Surg 1994;25(8):521-525.
      • Lee DA, Price FW, Whitson, WE. Intraocular complications associated with Dubroff anterior chamber lenses.  J Cataract Refract Surg 1994;20:421-425.
      • Whitcup SM, Nussenblatt RB, Price FW, Chan CC. Expression of cell adhesion molecules in corneal graft failure.  Cornea 1993;12(6):475-480.
      • Price FW, Whitson WE, Collins KS. Five-year corneal graft survival.  A large single-center patient cohort. Arch Ophthalmol 1993;111:799-805.
      • Wellemeyer ML, Price FW. Molteno implants in patients with previous cyclocryotherapy. Ophthalmic Surg 1993;24:395-398.
      • Coli AF, Price FW, Whitson WE. Intraocular lens exchange for anterior chamber IOL‑induced corneal endothelial damage. Ophthalmology 1993;100:384-393.
      • Lee DA, Price FW.  Management of concurrent corneal diseases and cataracts. Cur Opin Ophthalmol 1993,4;1:97-101.
      • Price FW, Whitson WE, Collins KS, Johns SK. Explantation of posterior chamber lenses. J Cataract Refract Surg 1992;18:475-479.
      • Price FW, Whitson WE, Collins KS, Johns SK. Changing trends in explanted intraocular lenses; a single center study. J Cataract Refract Surg 1992;18:470-474.
      • Whitson WE, Price FW. Reducing hypotony after Molteno procedure [letter; comment] Ophthalmic Surg 1992;23(6):434.
      • Price FW. Penetrating keratoplasty for keratoconus [letter; comment] Bri J Ophthalmol 1992;6(1):61.
      • Price FW, Whitson WE. Progression of visual acuity after penetrating keratoplasty. Ophthalmology 1991;98:1177‑1185.
      • Lopez JS, Price FW, Whitcup SM, Li Q, de Smet M, Chan CC. Immunohistochemistry of Terrien's and Mooren's Corneal Degeneration. Arch Ophthalmol 1991;109:988‑992.
      • Price FW, Whitson WE. Graft survival in four common groups of patients undergoing penetrating keratoplasty. Ophthalmology 1991;98:322‑328.
      • Price FW, Whitson WE. The art of surgical correction for postkeratoplasty astigmatism.
        Int Ophthalmol Clin. 1991 Winter;31(1):59-67.
      • Price FW, Whitson WE. Polypropylene ligatures with Molteno implants.
        Ophthalmic Surg. 1990 Aug;21(8):597.
      • Mamalis N, Craig MT, Price FW. Spectrum of Nd: YAG laser‑induced intraocular lens damage in explanted lenses. J Cataract Refract Surg 1990;16:495‑500.
      • Price FW, Whitson WE. Suprachoroidal hemorrhage after scleral‑fixated lens. J Cataract Refract Surg 1990;16(4):514‑515.
      • Price FW, Whitson WE. atural history of cystoid macular edema in pseudophakic bullous keratopathy. J Cataract Refract Surg 1990;16(2):163‑169.
      • Price FW, Whitson WE. Polypropylene ligatures as a means of controlling intraocular pressure with Molteno implants. Ophthalmic Surgery 1989;20:781‑783.
      • Apple DJ, Price FW, Gwin RT, Imkamp E, Daun M, Casanova R, Hansen S, Carlson AN. Sutured retro-pupillary posterior chamber IOLs for exchange or secondary implantation.  The 12th Annual Binkhorst Lecture, 1988. Ophthalmology 1989;96:1241‑1247.
      • Price, FW, Whitson, WE: Visual results of suture‑fixated posterior chamber lenses during penetrating keratoplasty. Ophthalmology 96;8:1234‑1240, 1989.
      • Price FW. Air lamellar keratoplasty. Refract and Corneal Surg 1989;5:240‑243.
      • Price, FW: A controlled method of removing the Stableflex lens. J Cataract Refract Surg 14:81‑83,1988.
      • Price FW. Factors contributing to corneal decompensation with Stableflex lenses. J Cataract Refract Surg 14:53‑57,1988.
      • Price FW, Binder PS. Scarring of recipient cornea following epikeratoplasty. Arch Ophthalmol 1987;105:1556‑1560.
      • Tetz MR, Apple DJ, Price FW, Piest KL, Kincaid MC, Bath, PE.  A newly described complication of neodymium‑YAG laser posterior capsulotomy: exacerbation of a subclinical intraocular infection. Arch Ophthalmol 1987;105:1324‑1325. 
      • Piest KL, Kincaid MC, Tetz MR, Apple DJ, Roberts WA, Price FW. Localized endophthalmitis: A newly described cause of the so‑called Atoxic lens syndrome.@ J Cataract Refract Surg 1987;13:498‑510.
      • Price FW, Schlaegel TF. Bilateral Acute Retinal Necrosis. Am J Ophthalmol 1980;89:419‑424. 

      Book Chapters

      1. Price MO, Price FW. Endothelial keratoplasty. In: Vajpayee (ed): Corneal Transplantation. El Dorado, Republic of Panama: Highlights of Ophthalmology, 2007 in press.
      2. Price FW, Price MO. Endothelial keratoplasy: visual and refractive outcomes. In John (ed): Endothelial Keratoplasty. In press.
      3. Price FW, Price MO. Descemet’s stripping with endothelial keratoplasty. In: Brightbill (ed): Corneal Surgery, Fourth Edition. London, England: Elsevier Ltd. in press.
      4. Price FW, Price MO. Endothelial keratoplasty. In: Yanoff, Duker (eds): Ophthalmology. London, England: Elsevier Ltd. in press.
      5. Price FW. I have a cataract patient with a traumatic iris defect and glare symptoms. What should I do? In: Chang DF (ed) Curbside Consultation in Cataract Surgery. Thorofare, NJ: Slack Inc. 2007; pp 31-35.
      6. Price FW, Price MO.  Descemet’s stripping and endothelial keratoplasty (DSEK).  In: Busin M, Arffa R. (eds) Atlas of microkeratome assisted lamellar keratoplasty Thorofare, NJ: Slack Inc.; 2006.
      7. Price FW.  “Lasik”. Focal Points; clinical modules for ophthalmologists, American Academy of Ophthalmology 2000; XVIII(3).
      8. Whitson WE, Price FW, Chang KC, Procope JA.  Automated lamellar keratoplasty. Cornea Vol 3, Chap 172;1996:2165-2179.
      9. Price FW. Keratomileusis. In: Nordan LT, Maxwell WA, Davison JA. (eds) The Surgical Rehabilitation of Vision “An integrated approach to anterior segment surgery” New York, NY, Gower Medical Publishing 1992.
      10. Price FW. Keratomileusis. In: Stamper RL, Thompson KP, Waring GO. (eds) Ophthalmology Clinics of N.A. “Contemporary refractive surgery” Philadelphia, PA, W.B. Saunders 1992, vol 5(4)673-681.
      Price FW, Whitson WE. The art of surgical correction for post keratoplasty astigmatism. In: International Ophthalmology Clinics Smolin G, Friedlaender MH, eds. Refract Surg Boston, Little, Brown & Co., 1991;vol 31,59‑67.

      Investigator – Clinical Trials

        • Surveillance of resistance to formulations of antimicrobials in cultures of the eye. Allergan, Inc. 2007/Active.
        • A Multi Center, Double Masked, Randomized Parallel Group Study Evaluating the Safety and Efficacy of a New Formulation of Ketorolac Tromethamine 0.45% Ophthalmic Solution Compared with Vehicle Administered Preoperatively and Twice-Daily Postoperatively for Two Weeks for the Treatment of Anterior Segment Inflammation, Pain, and Inhibition of Surgically Induced Miosis Following Cataract Extraction with Posterior Chamber Intraocular Lens (IOL) Implantation. Allergan, Inc. 2007/Active.
        • A prospective, randomized, multicenter center study evaluating the use of intraocular dexamethasone in conjunction with Descemet’s stripping and endothelial keratoplasty, a type of cornea transplant. Cornea Research Foundation of America and Ophthalmic Consultants of Long Island – 2007/Active.
        • Intraocular Pressure after Descemet’s stripping endothelial keratoplasty as measured by contour matching tonometry and applanation tonometry. Cornea Research Foundation of America – 2007.
        • Clinical evaluation of the safety and effectiveness of the Veriflex anterior chamber phakic IOL for the correction of myopia. Advanced Medical Optics – 2007/Active.
        • A multi-center, placebo-controlled, randomized, parallel-group, dose-ranging study to assess the efficacy and safety of LX201 implantation for the prevention of corneal allograft rejection episodes or graft failure in subjects who have experienced one or more rejection episodes following penetrating keratoplasty. Lux Biosciences – 2007/Active.
        • A multi-center, placebo-controlled, randomized, parallel-group, dose-ranging study to assess the efficacy and safety of LX201 for the prevention of allograft rejection episodes and graft failure following penetrating keratoplasty with LX201 implantation in subjects who are at increased immunological risk. Lux Biosciences – 2007/Active.
        • A prospective, multi-center feasibility trial to evaluate the safety and effectiveness of the IntraLase FS laser used to harvest donor tissue for Descemet’s stripping with endothelial keratoplasty.  IntraLase Corp. – 2007/Active.
        • A Randomized Evaluation of Two Surgical Kits: Gatifloxacin, Ketorolac LS, and Pred Forte Compared with Moxifloxacin, Nepafenac, and EconoPred in Patients Undergoing Cataract Surgery. William Trattler, MD – 2006.
        • Comparative Study of Corneal Transplant Survival and Endothelial Cell Loss following Descemet Stripping Automated Endothelial Keratoplasty vs. Penetrating Keratoplasty. Case Vision Research Coordinating Center – 2006/Active.
        • FECD Genetics Multi-Center Study.  Case Vision Research Coordinating Center – 2006/Active.
        • A prospective, randomized, single center study evaluating use of surgeon- and eye bank-prepared donor tissue for Descemet’s stripping and endothelial keratoplasty, a type of cornea transplant.  Protocol 2005-10. Cornea Research Foundation of America and the North Carolina Eye Bank, Inc. – 2006/2007.
        • A prospective, multi-center feasibility trial to evaluate the IntraLase FS laser used for penetrating keratoplasty.  Protocol FMTO-007-ITK.  IntraLase Corp. – 2005/2006.
        • Randomized, controlled, multicenter comparative trial to evaluate the SOLX Gold Shunt for the reduction of intraocular pressure (IOP) in glaucomatous eyes following failed medical and conventional surgical treatments.  Protocol SLX53.  SOLX – 2005/Active.
        • A masked comparison of Acular LS plus steroid versus steroid alone for the prevention of macular leakage in cataract patients.  Protocol. John Wittpenn, MD – 2005/2007.
        • Comparison of healing response of the corneal wound created by blade or femtosecond laser, in presence of implanted hydrogel sponge.  Protocol 2902. CooperVision – 2005.
        • A multi-center, double-masked, randomized, placebo controlled, evaluation of the onset and duration of action of R89674 0.25% ophthalmic solution in the conjunctival allergen challenge (CAC) model of acute allergic conjunctivitis.  Protocol 05-003-11.  Vistakon Pharmaceuticals, LLC – 2005/2006.
        • A study to determine whether early corneal protein changes associated with keratoconus can be identified through 2-dimensional gel electrophoresis and mass spectrometric analysis of human tear samples.  Protocol: K-10-03-001.  Cornea Research Foundation of America – 2004/2006.
        • A prospective, randomized, single-center clinical trial to evaluate the use of orbital seal sunglasses after LASIK.  Protocol 2004-20.  Panoptx – 2004/2005.
        • A prospective, randomized, multi-center clinical comparison of fellow eyes undergoing LASIK with either a mechanical keratome or IntraLase FS laser.  Protocol PRIM-016-CST.  IntraLase Corp – 2004/2005.
        • A prospective, single-center feasibility trial to evaluate the safety and effectiveness of the IntraLase FS laser used for corneal endostromal tissue harvesting.  Protocol FMTO-006-ITK.  IntraLase Corp – 2004/2005.
        • Clinical study of implantation of a UV-absorbing acrylic posterior chamber intraocular lens.  Protocol 2003-A101.  Hoya Holdings, Inc. – 2004/Active.
        • A study to determine if RestasisTM (cyclosporin 0.05% ophthalmic solution) is effective, either alone or in combination with pulsed dosing of corticosteroids, for prevention of graft rejection episodes after corneal transplantation.  Protocol R-09-03-002.  Price Vision Group - 2003/2005.
        • A prospective, randomized, double-masked study to evaluate whether pre-operative dosing with Acular LS is effective for maintaining pupil dilation and for mitigating pain and inflammation during and after cataract surgery.  Protocol A-09-03-001.  Price Vision Group - 2003/2004.
        • A Study to Compare the Effect of Gatifloxacin 0.3% and Moxifloxacin 0.5% Ophthalmic Solutions on Corneal Epithelial cell health following two dosing regimens.  Protocol 08-03-001.  Price Vision Group - 2003.
        • A comparison of the duration of IOP control with travopost, bimatoprost, and latanoprost in patients with glaucoma and ocular hypertension: a multicenter, randomized, masked-evaluator, parallel group study.  Protocol 03-005-03.  Ophthalmic Research Associates - 2003.
        • To evaluate the effect of gatifloxacin 0.3% ophthalmic solution on corneal endothelial cell counts in two subpopulations:  non-surgical, normal healthy volunteers and healthy volunteers scheduled to undergo standard cataract surgery.  Protocol PIND-GATI-004.  Allergan – 2003. 
        • A comparative study of olopatadine QD versus vehicle in patients with seasonal allergic conjunctivitis or rhinoconjunctivitis.  Protocol C-02-67.  Alcon – 2003.
        • Medical Monitor and Principal Investigator – Multicenter Clinical Study of the Ophthec Model 311 Iris Reconstruction Lens.  FDA IDE Number: G020127 and G020127/A001.  OPHTEC USA, Inc. - 2002/Active
        • Principal Investigator – Multicenter Clinical Study of the OCULAID Endocapsular Tension Ring (CTR) and OPERAID Tension Ring Inserter.  FDA IDE Number: G010064.  Protocol CTR 275/276. OPHTEC USA, Inc.– 2001/2004
        • Principal Investigator – A multi-center, randomized, double-masked, vehicle-controlled, parallel-group study evaluating the safety and analgesic efficacy of Ketorolac Tromethamine 0.4% ophthalmic solution in post photorefractive keratectomy patients.  Protocol 191578-003. Allergan – 2001/2002
        • Principal Investigator – A prospective, masked study comparing preservative-free Acular to vehicle for analgesic efficacy after LASIK.  Allergan – 2000/2001.
        • Principal Investigator – A prospective, masked study to compare the effectiveness of antibiotics to penetrate into the eye.  Allergan – 2000/2001.
        • Principal Investigator – The Cornea Donor Study: A prospective cohort study to determine whether the graft-failure rate over a 5-year follow-up period is equivalent with corneal tissue from donors older than 65 years of age compared with that from younger donors.  Two other specific objectives also evaluated.  Protocol Version 1.0- Jaeb Center for Health Research – 1999/Active
        • Co-Investigator - Clinical evaluation of a new method to remove the Landec Punctal Occluder. Protocol C-98-15. Alcon Laboratories, Inc. – 1999
        • Principal Investigator - US Clinical Study of the Artisan Myopia Lens for the Correction of High Myopia in Phakic Eyes. Ophtec USA, Inc. - 1998/2007
        • Principal Investigator and Sponsor - A Phase III Prospective Controlled Clinical Trial to Investigate the Ability to Decrease the Rate of Over-correction without Increasing the Rate of Retreatment due to Under-correction with Laser in Situ Keratomileusis.  EXKM-802.   Protocol 980968. Corneal Consultants of Indiana – 1998-9/2000
        • Principal Investigator - Clinical study of the implantable contact lens for patients with moderate to high hyperopia.  Protocol 980363. STAAR® Surgical – 1998-4/2000
        • Principal Investigator - A Phase III study of MDX-RA compared with placebo administered in
        • patients undergoing phacoemulsification or planned extracapsular extraction for cataract.  Protocol CL-SEC014.  - Medarex, Inc. 1998-4/2000
        • Principal Investigator - A Multi-Center Prospective Clinical Study to Evaluate the Use of the LADARVision Excimer Laser System in LASIK Correction of Hyperopia and Astigmatism. Protocol 7201-0022. Autonomous Technologies Corporation – 1998-3/2000
        • Principal Investigator - A Multi-Center Prospective Clinical Study to Evaluate the Use of LADARVision System in Correction of Hyperopia and Astigmatism. Protocol 7201-0010. Autonomous Technologies Corporation - 1998/1999
        • Principal Investigator and Sponsor  - A Phase III prospective randomized controlled clinical trial to investigate the use versus non-use of topical corticosteroids on the stability of the manifest refraction after the surgical correction of myopia and astigmatism with laser in situ keratomileusis. Protocol EXKM-801. Corneal Consultants of Indiana - 1997/2000
        • Principal Investigator and Sponsor - A Phase III prospective randomized controlled clinical trial to investigate the simultaneous versus sequential surgical correction of myopia and astigmatism with laser in situ keratomileusis.  Protocol EXKM-800.  Corneal Consultants of Indiana – 1996
        • Co-Investigator for a Phase III prospective multi center clinical trial to evaluate the safety of the Chiron Technolas™ Keracor™ 116 excimer laser for the correction of mild myopia and astigmatism in fellow eyes of subject initially treated under protocol EXCM-650-MYO.  Protocol EXCM-651-FEL.  Chiron Vision Corp. – 1995
        • Co-Investigator for a Phase III prospective multi center clinical trial to evaluate the safety and effectiveness of the Chiron Technolas™ 116 excimer laser for the correction of mild myopia.  Protocol EXCM-650-MYO.  Chiron Vision Corp. – 1995
        • Co-Investigator for a protocol for the retreatment of eyes with under-corrected refractive error following photorefractive keratectomy with the Chiron Technolas™ Keracor™ 116 excimer laser. Protocol EXCM-622-RET.  Chiron Vision Corp. – 1995
        • Co-Investigator for a clinical trial to evaluate the use of the Chiron Technolas Keracor™ 116 excimer laser for the correction of residual myopia or of untreated fellow eyes in patients treated with the Taunton 2015 excimer laser.  Protocol EXCM-620-TET.  Chiron Vision Corp. – 1995
        • Principal Investigator for the analgesic efficacy of ketorolac tromethamine 0.5% diclofenac sodium 0.1% when used following bilateral radial keratotomy.  Allergan Pharmaceuticals – 1995
        • Principal Investigator for a Phase II prospective randomized controlled multi center clinical trial to compare surgical correction of myopia with excimer laser photorefractive keratectomy versus laser in situ keratomileusis. Protocol EXKM-603-MYO. Chiron Vision Corp.- 1995
        • Principal Investigator for a Phase II multi center clinical trial to evaluate the use of the excimer laser for the treatment of superficial corneal opacities.  Protocol EXCM-615-PTK.  Chiron Vision Corp. – 1994
        • Principal Investigator for a retrospective ALK study.  Submitting 100 patients.  Refractive Services Agency – 1994
        • Principal Investigator for the analgesic efficacy and safety of KETOROLAC non-preserved ophthalmic solution in subjects undergoing radial keratotomy.  Study KETO-105-8718  Allergan - 1994/1995
        • Principal Investigator for a randomized open clinical trial for the evaluation of corneal tissue levels following topical dosing with OCUFLOX solution.  Allergan – 1994
        • Principal Investigator for an adjunctive therapy with Galardin™ matrix metalloproteinase inhibitor (GM 6001) in patients with corneal ulcers caused by infection.  Galardin - 1993/1994
        • Principal Investigator for a retrospective multi center clinical study to evaluate the clinical outcome of keratorefractive surgery for the correction of myopia and astigmatism.  Chiron IntraOptics -1992/1993 
        • Principal Investigator for a prospective multi center clinical trial to evaluate keratorefractive surgery for the correction of myopia and astigmatism.  Chiron IntraOptics - 1992/1993 
        • Principal Investigator for a prospective multi center clinical trial to evaluate keratorefractive surgery for the correction of myopia.  Chiron IntraOptics - 1992/1993
        • Principal Investigator for a randomized open clinical trial for the evaluation of corneal tissue levels following topical dosing with CILOXAN solution.  Alcon Laboratories - 1992/1993
        • Principal Investigator for clinical trials to evaluate the excimer laser used for photorefractive keratectomy (PRK), Phase III ‑ VISX Incorporated - 1992-1994
        • Principal Investigator for clinical trials to evaluate the excimer laser for use in phototherapeutic corneal surgery (PTK), Phase IIB - VISX Incorporated - 1992-1995
        • Principal Investigator for a randomized, double‑masked clinical trial to assess the safety and comparative efficacy of three concentrations of Sandimmune ophthalmic ointment versus placebo in patients with keratoconjunctivitis sicca. ‑ Sandoz Research Institute - 1991
        • Principal Investigator for a clinical trial to evaluate the handling, fit, retention, and comfort of the Chiron corneal shield in postoperative patients. ‑ Chiron Ophthalmics, Inc.- 1991
        • Principal Investigator for intraocular pressure raising potential of Rimexolone in high steroid responders. ‑ Alcon Laboratories - 1991/1992
        • Principal Investigator for a randomized controlled multi center study to evaluate the effect of collagen shields on corneal epithelialization following pene­trating keratoplasty.  Chiron Ophthalmics, Inc. – 1991
        • Principal Investigator for clinical trials to evaluate the safety and efficacy of Sandimmune 2% Ophthalmic Ointment in the prevention of corneal graft rejection following "high risk" keratoplasty.  Sandoz Research Institute, East Hanover, NJ - 1989-1992
        • Principal Investigator for placebo‑controlled study to evaluate the safety and efficacy of Fibronectin ophthalmic solution in patients with keratoconjunctivitis sicca.  Chiron Ophthalmics, Inc., Irvine, CA - 1988-1990
        • Principal Investigator for clinical evaluation of corneal preser­vation media containing human Epidermal Growth Factor and insulin.  Chiron Ophthalmics, Inc., Irvine, CA - 1988-1990
        • Principal Investigator for the clinical evaluation of a hydrogel intracorneal implant (Kerato‑Gel) for the correction of aphakia;  Allergan Medical Optics, Santa Ana, CA – 1988
        • Principal Investigator for the clinical evaluation of a hydrogel intracorneal implant (Kerato‑Gel) for the correction of myopia;  Allergan Medical Optics, Santa Ana, CA – 1988
        • Principal Investigator for Fibronectin used in the treatment of recurrent corneal erosions;  Chiron Ophthalmics, Inc., Irvine, CA  1987/1988
        • Principal Investigator for Fibronectin used in the treatment of persistent corneal defects;  Chiron Ophthalmics, Inc., Irvine, CA  1987/1988
        • Principal Investigator for human Epidermal Growth Factor to promote healing of penetrating keratoplasties; Chiron Ophthalmics, Inc. - 1986/1987
        • Principal Investigator for human Epidermal Growth Factor to promote healing of non‑healing corneal defects; Chiron Ophthalmics, Inc., Irvine, CA - 1986/1987
        •  Investigator for BKS‑1000 ‑ Non-Freeze Keratomileusis; American Medical Optics,  Irvine, CA - 1986

        Manuscript review panel member for the following:

        REFRACTIVE AND CORNEAL SURGERY

        ARCHIVES OF OPHTHALMOLOGY
        OPHTHALMOLOGY
        OPHTHALMIC SURGERY AND LASERS
        CORNEA
        JOURNAL OF REFRACTIVE SURGERY
        JOURNAL OF CATARACT AND REFRACTIVE SURGERY
        BRITISH JOURNAL OF OPHTHALMOLOGY

        Editorial Board for Therapeutic Updates in Ophthalmology
        Quarterly publication of Ocular Surgery News and published by SLACK, Inc. 1997/2007
        (Pain Section Editor since 2003)

        Editorial Board for Journal of Refractive Surgery Official publication of the International Society of Refractive Surgery and published by SLACK, Inc. Active

        Medical advisor
        Glaucoma setons for STAAR Surgical, Monrovia, California 1992-1997

        Medical Advisory Board

        National Keratoconus Foundation – 2003/Active

         

        Presentations

        1. Safety of femtosecond laser-assisted penetrating keratoplasty performed in two stages at separate sites. Annual meeting of the American Academy of Ophthalmology November 12, 2007, New Orleans, LA.
        2. The effect of intracameral dexamethasone on visual outcomes in Descemet-stripping automated endothelial keratoplasty. Annual meeting of the American Academy of Ophthalmology November 11, 2007, New Orleans, LA.
        3. Graft Rejection Episodes After DSEK: Incidence, Risk Factors and Clinical Findings, Cornea Society Federated Scientific Session, Nov 9, 2007, New Orleans, LA. 
        4. What is the Best Method for Assessing IOP after DSEK? Cornea Society Federated Scientific Session, Nov 9, 2007, New Orleans, LA. 
        5. Endothelial transplantation : technique and results. ESCRS. September 7, 2007.  Stockholm, Sweden.
        6. Femtosecond laser contoured keratoplasty: Healing and visual outcomes. ESCRS. September 11, 2007.  Stockholm, Sweden.
        7. Beyond femto LASIK: Femtolaser endothelial transplants. ESCRS. September 11, 2007.  Stockholm, Sweden.   
        8. Descemet’s stripping endothelial keratoplasty.  Argentinean Congress of Ophthalmology.  July 21, 2007.  Buenos Aires, Argentina.  .
        9. New options in corneal transplant surgery. Argentinean Congress of Ophthalmology.  July 21,2007.   Buenos Aires, Argentina.  .
        10. Endothelial transplants; experience and results: Breakfast with the expert.  Argentinean Congress of Ophthalmology.  July 20, 2007. Buenos Aires, Argentina. 
        11. Descemet stripping lamellar endokeratoplasty.  Joint SOE/AAO Congress.  June 10, 2007.  Vienna, Austria.
        12. Femtosecond lasers in corneal transplant surgery.  Joint SOE/AAO Congress.  June 10, 2007. Vienna, Austria
        13. Logistical and practical aspects of performing FSL-assisted PK in a laser center and then ASC.  12th Annual Joint Meeting of SOI, OSN and AICCER.  May 25, 2007.  Rome, Italy. 
        14. Endothelial keratoplasty: what we have learned in over 900 cases in our practice.  12th Annual Joint Meeting of SOI, OSN and AICCER.  May 25, 2007.  Rome, Italy.   
        15. Outcomes analysis of DSEK: eye-bank precut vs. surgeon-dissected donor tissue. American Society of Cataract and Refractive Surgery, April 28, 2007; San Diego CA.(Best Paper of Session).
        16. Analysis of factors influencing endothelial cell loss after DSEK: 2-year follow-up. American Society of Cataract and Refractive Surgery, April 28, 2007; San Diego CA.
        17. Endothelial keratoplasty: current state of the art and impact on cataract surgery decision-making. American Society of Cataract and Refractive Surgery, April 28, 2007; San Diego CA
        18. Penetrating Keratoplasty with a femtosecond laser using an independent laser refractive center.  American Society of Cataract and Refractive Surgery, April 28, 2007; San Diego CA.
        19. Implantable contact lens sizing: manual white-to-white versus VHF digital ultrasound imaging. American Society of Cataract and Refractive Surgery, April 28, 2007; San Diego CA.
        20. Endothelial keratoplasty: Changing outlook for corneal transplants and cataracts.  March 3, 2007.  50th Annual Postgraduate Symposium in Ophthalmology-Ohio State University Medical Center.  Columbus, OH
        21. Therapeutic applications of femtosecond lasers: From PK to AK.  March 3, 2007.  50th Annual Postgraduate Symposium in Ophthalmology-Ohio State University Medical Center.  Columbus, OH
        22. Top-hat shaped penetrating keratoplasty.  Hawaiian Eye 2007.  January 13, 2007.  Kauai, HI.
        23. Future directions: Deep lamellar and beyond.  Hawaiian Eye 2007.  January 13, 2007.  Kauai, HI.  
        24. Innovations and emerging technologies in vision research. Indiana Health Industry Forum Life Science Initiative, Nov 22, 2006, Indianapolis, IN. 
        25. Factors affecting endothelial cell density and 2 year trend after Descemet’s stripping with endothelial keratoplasty.  Eye Bank Association of America Federated Scientific Session, Nov 10, 2006; Las Vegas, NV.
        26. Comparative outcomes with eye bank or surgeon dissected donor tissue for Descemet’s stripping endothelial keratoplasty. Eye Bank Association of America Federated Scientific Session, Nov 10, 2006; Las Vegas, NV.
        27. Early experience with femtosecond laser assisted penetrating keratoplasty. Eye Bank Association of America Federated Scientific Session, Nov 10, 2006; Las Vegas, NV.
        28. Collagen crosslinking for ectasia: Does it make sense?  American Academy of Ophthalmology annual meeting November 10, 2006. Las Vegas, NV 
        29. Model 311 Iris reconstruction lens United States clinical trial: three year outcomes.  American Academy of Ophthalmology annual meeting Nov 11-14, 2006. Las Vegas, NV (Best Poster award).
        30. Femtosecond laser contoured penetrating keratoplasty: one year outcomes.  American Academy of Ophthalmology annual meeting Nov 11-14, 2006. Las Vegas, NV
        31. Cornea-based refractive surgery.  OSN New York 2006.  October 14, 2006.  New York, NY 
        32. Femtosecond laser assisted tophat-shaped penetrating keratoplasty: healing and suture removal times with varied wound dimensions.  (2006) XXIV Congress of the European Society of Cataract & Refractive Surgeons, Sept 9-13, London, England.
        33. Corneal transplants: why and when.  2006 Fuchs’ Corneal Dystrophy Symposium.  June 17, 2006.  Orlando, FL
        34. Comparative incidence of epithelial in-growth after LASIK retreatment in eyes originally treated with a mechanical microkeratome or the femtosecond laser.  May 26, 2006.  19th Congress of German Ophthalmic Surgeons.  Nuremberg, Germany. 
        35. Descemet’s stripping with endothelial keratoplasty.  May 27, 2006.  19th Congress of German Ophthalmic Surgeons.  Nuremberg, Germany.
        36. Femtosecond laser assisted penetrating keratoplasty.  May 27, 2006. 19th Congress of German Ophthalmic Surgeons.  Nuremberg, Germany.  May 27, 2006. 19th Congress of German Ophthalmic Surgeons.  Nuremberg, Germany.
        37. Latest news on the IntraLase femtosecond laser.  May 26, 2006.  19th Congress of German Ophthalmic Surgeons.  Nuremberg, Germany.
        38. Optical indications: Lamellar Endokeratoplasty.  May 25, 2006.  19th Congress of German Ophthalmic Surgeons.  Nuremberg, Germany.         
        39. Use of a femtosecond laser to create stepped corneal incisions in subjects undergoing penetrating keratoplasty.  (May 2006).  Association for Research in Vision and Ophthalmology annual meeting, Fort Lauderdale, FL.
        40. First 100 Eyes in U.S. Clinical Trial of the Model 311 Iris Reconstruction Lens:  1-Year Outcome Analysis. (March 2006), American Society for Cataract and Refractive Surgery, San Francisco, CA. (Best Paper of Session)
        41. Influence of Original Flap Creation Method on Incidence of Epithelial Ingrowth after LASIK Retreatment. (March 2006) American Society for Cataract and Refractive Surgery,
          San Francisco, CA
        42. Correlation of Visual Acuity with Corneal Thickness and Donor Contour after Descemet’s Stripping with Endothelial Keratoplasty. (March 2006) American Society for Cataract and Refractive Surgery, San Francisco, CA (Best Paper of Session)
        43. Corneal transplantation as refractive surgical procedure: endothelial lamellar keratoplasty with and without intraocular lenses.  February 21, 2006.  World Ophthalmology Congress.  Sao Paulo, Brazil. 
        44. Adaptation of posterior keratoplasty to restore clarity to failed penetrating grafts. Eye Bank Association of America Federated Scientific Session (2005), Chicago, IL.
        45. Price MO, Price FW.  Efficacy of Cyclosporine 0.05% for prevention of cornea transplant rejection. (2005) American Academy of Ophthalmology Annual meeting, Chicago, IL. (Best Poster award)
        46. Comparative Visual Outcomes using automated- or hand-dissected donor tissue for posterior corneal grafts.  (2005) American Academy of Ophthalmology Annual meeting, Chicago, IL.
        47. Descemet’s stripping with endothelial keratoplasty (DSEK): Early outcomes in an initial series of 240 consecutive eyes. (2005), Eye Bank Association of America Federated Scientific Session Chicago, IL.
        48. Use of orbital seal eyewear in post-LASIK patients. (2005) American Society for Cataract and Refractive Surgery, Washington, DC.
        49. Effect of Gatifloxacin Ophthalmic Solution 0.3% on Corneal Endothelial Cell Counts in Normal Subjects and in Cataract Surgery Patients. (2004) Association for Research in Vision and Ophthalmology, Fort Lauderdale, FL.
        50. Penetration of Gatifloxacin Ophthalmic Solution 0.3% into Human Aqueous Humor of Patients Undergoing Cataract Surgery. (2004)Association for Research in Vision and Ophthalmology, Fort Lauderdale, FL.
        51. Posterior lamellar corneal transplants for endothelial diseases.  (2003)  American Society for Cataract and Refractive Surgery, San Francisco, CA.
        52. Posterior lamellar corneal transplants for endothelial diseases.  (2003)  American Society for Cataract and Refractive Surgery, San Francisco, CA.
        53. Safety and efficacy of reformulated Ketorolac Tromethamine 0.4% ophthalmic solution in post photorefractive keratectomy patients.  Annual meeting ARVO, May 4-9, 2003, Ft. Lauderdale, FL.
        54. Does the Amadeus Microkeratome offer advantages.  American Society of Cataract and Refractive Surgery (ASCRS ) 2002 Philadelphia, PA.
        55. Viscoelastic material as an adjunct to dissections and to treat microperforations during nonpenetrating filtering surgery. American Society of Cataract and Refractive Surgery (ASCRS) 2000  San Diego, CA
        56. A prospective, randomized comparison of the use versus non-use of topical corticosteroids after laser in situ keratomileusis (LASIK).  American Academy of Ophthalmology Annual Meeting '99 Orlando, FL 10/26/99
        57. Artisan Myopia Claw Lens for High Myopia.  American Society of Cataract and Refractive Surgery (ASCRS) ’99.  Seattle, WA 4/12/99
        58. LASIK for Hyperopia (1 to 6D) with astigmatism (-0.5 to -6D) with the Autonomous Technologies LADARVision System.  American Society of Cataract and Refractive Surgery (ASCRS) ’99. Seattle, WA 4/11/99
        59. Prosthetic Iris Implants and Their Role in Both Cosmetic and Functional Reconstruction of the Anterior Chamber.  American Society of Cataract and Refractive Surgery (ASCRS) ‘99   Seattle, WA 4/11/99
        60. LASIK Results: Plano to -22".  Hyperopic PRK - Early Experiences.  Hawaii ‘99 Ocular Surgery News - Slack, Inc.  Big Island of Hawaii  1/29/99
        61. Goals & Keeping Them in Perspective.  Hawaii ‘99 Ocular Surgery News - Slack, Inc. Lifestyle Management Program.  Big Island of Hawaii  1/27/99
        62. Painless PRK: Is it possible?  Annual Meeting - American Academy of Ophthalmology - New Orleans, LA 11/6/98
        63. What’s New! Surgical & Therapeutic Options.  Focus on Education - Update 1998 - Cornea Research Foundation of America.  Indianapolis, IN 10/17/98
        64. STAAR collagen wick: surgical technique.  STAAR Surgical - ASCRS, San Diego.  04/20/98
        65. Choosing antibiotics for the perioperative setting.  Ocular Surgery News - Slack Inc. - ASCRS, San Diego.  04/18/98
        66. Improving cataract outcomes.  Refractive surgery/LASIK: indications, technique and outcomes.  Annual meeting - New Mexico Ophthalmological Society, Albuquerque, NM, 02/21/98
        67. Central corneal thickness in refractive surgery.  Annual meeting - International Society of Refractive Surgery (ISRS).  San Francisco, CA, 10/25/97
        68. LASIK: Indications, technique and outcomes.  First Annual University of  Illinois Cornea Symposium.  Chicago, IL 09/10/97
        69. The widening scope of NSAIDs in cataract and refractive surgeries (RK, PRK and LASIK).  Ophthalmology Society of Cincinnati and Dayton. Cincinnati, OH 08/25/97
        70. Topical nonsteroidals and pain relief.  Is there still a role for incisional keratotomies?  "Videorefrattiva '97, III Congresso Internazionale Di Chirurgia Refrattiva."  Milan, ITALY  03/2122/97
        71. The widening scope of NSAIDs in ophthalmic surgery - ocular pain management.  Optional use of nonsteroidal anti-inflammatories in Ophthalmic Surgery Symposium. Ocular Surgery News - Slack Inc., Scottsdale, AZ  02/27-28/97
        72. The widening scope of NSAID use in ophthalmic surgery - ocular pain management - Part II.  Hawaii '97 Ocular Surgery News Special Event - Slack Inc.,   Maui, HI  01/27/97
        73. Keratomileusis in situ (automated lamellar keratoplasty) - what are the strengths and weaknesses?  LASIK Didactic Course American Academy of Ophthalmology Annual Meeting, Chicago, IL  10/27/96
        74. Astigmatic treatment with the excimer laser; a case for not using astigmatic keratotomy.  Sub-Specialty Day 1996 - Reshaping the Future: Refractive Surgery.  American Academy of Ophthalmology Annual Meeting, Chicago, IL  10/25/96
        75. Interactive computing - the key to improving office efficiency and decreasing overhead.  International Society of Refractive Surgery, Pre-American Academy of Ophthalmology Meeting, Chicago, IL  10/25/96
        76. Current status of LASIK.  Indiana Academy of Ophthalmology Annual Meeting, Indianapolis, IN  06/14/96
        77. Current status of refractive surgery.  Section Meeting of Family Practice Physicians of St. Vincent Hospital, Indianapolis, IN  05/16/96
        78. Changing risk factors for penetrating keratoplasty.  World Congress on the Cornea IV, Orlando, FL 04/17/96
        79. The medical management of radial keratotomy.  Certified Ophthalmic Dispensers Assn. Annual Convention & Trade Show, Indianapolis, IN 11/04-05/95
        80. Computerized interactive patient education/informed consent for  refractive surgery.  Comparison of topical Acular versus Voltaren for pain relief after radial keratotomy.  International Society of Refractive Surgery, Pre-American Academy of Ophthalmology Meeting, Atlanta, Georgia 10/27/95
        81. Post-op care: modulation of healing.  Focus on Education - Update 1995.  Indianapolis, IN 09/09/95
        82. Topical NSAIDS.  Update on automated lamellar keratoplasty/LASIK. Cincinnati Ophthalmological Society, Cincinnati, Ohio  06/08/95
        83. Corneal tissue level of topically applied Ocuflox.  ASCRS/ASOA Symposium on Cataract, IOL and Refractive Surgery, San Diego, CA  04/04/95
        84. Medical and surgical management of glaucoma.  Indiana School of Optometry, Bloomington, IN  01/26/95
        85. Corneal tissue levels of ciprofloxin in eyes undergoing penetrating keratoplasty.  A refractive surgery called keratomileusis. FUHS/Chicago Medical School Grand Rounds Chicago, IL  11/30/94
        86. Medical and surgical management of glaucoma.  Central Indiana Optometric Society, Indianapolis, IN  11/08/94
        87. Automated lamellar keratomileusis: predictability and stability.  International Society of Refractive Keratoplasty, Pre-American Academy of Ophthalmology Meeting, San Francisco, CA  10/28/94
        88. Keratoplasty and other refractive options.  Central Indiana Optometric Society, Lafayette, IN  10/25/94
        89. Nonsteroidal anti-inflammatory drugs (NSAIDs) in refractive surgery; how, why, and when?  Automated lamellar keratomileusis (ALK); where does it fit into  refractive surgery?  Washington D.C. Ophthalmological Society Meeting, Washington, DC  09/08/94
        90. Astigmatic Reduction Clinical Trial (ARC-T) - Report on predictability and safety. Indiana Academy of Ophthalmology, Seventy-Seventh Annual Scientific Meeting, Indianapolis, IN  06/1011/94
        91. Nonsteroidal anti-inflammatory drugs (NSAIDs) Keratomileusis in situ.  Indiana Optometric Association, Annual Meeting of Formulary Update, Indianapolis, IN  06/09/94
        92. Automated lamellar keratomileusis (ALK).  Northern Indiana Optometric Association, Annual Meeting, Fort Wayne, IN 3/94
        93. Central Islands - Nonpenetrating glaucoma filtration surgery.  ASCRS/ASOA Symposium on Cataract, IOL and Refractive Surgery, Boston, MA 04/09-13/94
        94. Non-penetrating glaucoma filtration surgery, utilizing a collagen inlay.  15th Annual Royal Hawaiian Eye Meeting, Maui, HI  01/20/94
        95. A new corneal punching system.  Eye Bank Association of America (EBAA) - 32nd Annual Scientific Session Pre-American Academy of Ophthalmology Meeting, Chicago, IL  11/13/93
        96. Central Islands - Fact or fiction?  Astigmatic Reduction Clinical Trial (ARC-T) Safety and changes in best-corrected visual acuity.  Astigmatic Reduction Clinical Trial (ARC-T) Report on predictability of the nomogram.  International Society of Refractive Keratoplasty (ISRK) Pre-American Academy of Ophthalmology Meeting, Chicago, IL  11/12-13/93
        97. Non-Steroidals in ophthalmology.  Decision making in management of IOL complications. Radial keratotomy.  Residents and faculty of Ophthalmology Department at Loyola University, Chicago, IL  04/28/93
        98. Poster 4185 - Corneal tissue levels of topically applied ciprofloxacin.  Annual Meeting - The Association for Research in Vision and Ophthalmology (ARVO), Sarasota, FL  05/2-7/93
        99. Incisional refractive surgery: An overview.  Risk factors for corneal graft failure.  Annual Meeting - American Academy of Ophthalmology, Dallas, TX  11/8-12/92
        100. Excimer laser trials.  75th Annual Meeting - Indiana Academy of Ophthalmology, Indianapolis, IN 06/12-13/92
        101. Suprachoroidal hemorrhage in penetrating keratoplasty.  Khandaker Ahad, M.D., Francis Price, Jr., M.D., William Whitson, M.D.  95th Annual Meeting - American Academy of Ophthalmology: Anaheim, CA, 10/13-17/91
        102. Scientific Poster 43 - Intraocular lens exchange for anterior chamber IOL-induced corneal endothelial damage.  Arthur Coli, M.D., Francis W. Price, Jr., M.D., William E. Whitson, M.D Free Paper 30-4
        103. What's new in refractive surgery.  Current data on penetrating keratoplasty survival.  1991 Scientific Assembly ‑ National Medical Association, Indianapolis, IN 07/31/91
        104. Changing trends in intraocular lens removals and how this influences future cataract surgery and intraocular lens implantation.  74th Annual Meeting ‑ Indiana Academy of Ophthalmology Indianapolis, Indiana, 04/26/91
        105. Changing trends in explanted intraocular lenses.  Explanation of posterior chamber lenses.  Use of intraocular endoscopic camera.  A new posterior chamber lens specifically designed for suturing  to the iris.  ASCRS Symposium of Cataract, IOL and Refractive Surgery, Boston, Massachusetts, 04/7‑10/91
        106. Corneal graft survival and the influence of intraocular lenses.  Annual Meeting‑Indiana Academy of Ophthalmology, Indianapolis, Indiana, 04/20/90
        107. Corneal damage and complications following IOL surgery.  25th Annual Meeting ‑ The American Society of Contemporary Ophthalmology, Phoenix, Arizona, 03/29/90
        108. Overview ‑ Surgical correction of myopia.  Iris‑fixated posterior chamber lenses using a straight taper point needle. Intraocular Implant Lens Update 1989 ‑ Part I and Part II - Annual Meeting ‑ American Academy of Ophthalmology, New Orleans, Louisiana, 11/01/89
        109. Life‑table analysis of corneal transplants for bullous keratopathy, Fuchs' corneal dystrophy and keratoconus.  1989 Eye Bank Association of America Scientific Session, New Orleans, Louisiana, 10/28/89
        110. Suture‑Fixating current styles of posterior chamber lenses to the iris.  Kerato‑Gel corneal inlay technique and patient selection.  ASCRS/ASOA 2nd American‑Int'l Congress, Washington, D.C., 04/25‑27/89
        111. Design of early results of an epidemiologic study of eyes receiving Stableflex and anterior lenses.   Early results and observations with hydrogel corneal inlays for the treatment of aphakia.  Indiana Academy of Ophthalmology, Indianapolis, Indiana, 04/07/89
        112. Suture‑fixated posterior chamber lenses and the treatment of pseudophakic bullous keratopathy and cystoid macular edema.  Best and worst cases in myopic keratomileusis.  CLAO/ISRK Annual Meeting, New Orleans, Louisiana, 01/19‑20/89
        113. Suture‑fixated posterior chamber lenses in the treatment of pseudophakic bullous keratopathy and cystoid macular edema.  Suture‑fixating posterior chamber lenses to the iris.  Welsh Cataract Congress, Houston, Texas, 11/17/88
        114. Visual results of suture‑fixated posterior chamber lenses during penetrating keratoplasty.  American Academy of Ophthalmology, Las Vegas, Nevada, 10/10/88
        115. Cystoid macular edema in pseudophakic bullous keratopathy ‑ does glaucoma affect the outcome?  Indiana Academy of Ophthalmology, Indianapolis, IN   04/23/88
        116. Visual distortions after keratorefractive surgery.  KeratoRefractive Society Annual Symposium, Dallas, Texas,  11/07/87
        117. Epidermal growth factor in ophthalmology.  Visual complications of refractive surgery.  Current Trends of Ophthalmology Symposium, Minneapolis, Minnesota, 09/10/87
        118. What went wrong with the Stableflex lens?  Factors in lens design that influence intraocular lens removal.  Annual Meeting: Indiana Academy of Ophthalmology, Indianapolis, Indiana, 05/02/87
        119. Femtosecond laser contoured penetrating keratoplasty: one-year outcomes.  (2006) American Academy of Ophthalmology annual meeting Nov 11-14, Las Vegas, NV.
        120. Factors in lens design that influence intraocular lens removals.  What went wrong with the Stableflex lens?  ASCRS Symposium:  Orlando, Florida, 04/08/87
        121. Permanent scarring of recipient cornea after removal of epikeratophakia.  World Congress on the Cornea III: Washington, DC, 04/30/87
        122. Permanent scarring of recipient cornea after removal of epikeratophakia.  CLAO/ISRK Combined Midwinter Meeting: Las Vegas, NV  01/15/87
        123. Visual side effects of refractive surgery. Introduction to refractive corneal surgery.  Keratophakia. Intrasomal (alloplastic) corneal inlays.  Keratomileusis ‑ current status of MKM in the United States.  Contact lens fitting after refractive surgery.  Annual Meeting ‑ Indiana Academy of Ophthalmology: South Bend, Indiana 05/30‑31/86
        124. The use of posterior chamber intraocular lenses as a secondary implant with corneal transplants.  Annual Meeting ‑ Indiana Academy of Ophthalmology: French Lick, Indiana, 05/05/84
        125. Prevention of posterior capsule opacification by cryotherapy.  IOLAB Update ‑ Anterior and Posterior Chamber Intraocular Lens Seminar with Cryotherapy Update: Indianapolis, Indiana, 07/83
        126. Treatment of recurrent pterygium by argon laser photocoagulation.  Annual Meeting ‑ Indiana Academy of Ophthalmology: French Lick, Indiana, 05/06/83
        127. The effect of topical glycerin on the normal corneal endothelium.  U.S. Intraocular Lens Symposium: Los Angeles, California, 04/82

         

        Instructional Courses

        1. Course Director. Advanced Corneal Surgical Techniques. Price Vision Group, Indianapolis, IN.  Provided surgical training for more than 380 physicians from 45 U.S. states and 16 foreign countries, including Argentina, Austria, Brazil, Canada, Germany, Iceland, India, Iran, Japan, Jordan, Korea, Malaysia, Portugal, Serbia, Switzerland, United Arab Emirates.  Dates: Nov 5-6, 2002; Mar 25-26, 2003; Sept 30 – Oct 1, 2003; Feb 10-11, 2004; May 11-12, 2004; July 20-21, 2004; Sept 27-28, 2004; Dec 7-8, 2004; Jan 16-17, 2005; Feb 8-9, 2005; April 26-27, 2005; June 14-15, 2005; July 26-27, 2005; Aug 23-24, 2005; Sept 20-21, 2005; Oct 4-5, 2005; Oct 19-20, 2005; Nov 29-30, 2005; Dec 6-7, 2005; 16 courses Jan 2006-Dec 2006; 10 courses Jan 2007-Sept 2007.
        1. Instructor: Update on posterior lamellar keratoplasty/ Descemet’s membrane transplantation (DSEK/DSAEK/FS-DSEK and DMEK). Annual meeting of the American Academy of Ophthalmology November 12, 2007, New Orleans, LA.
        2. Instructor: New and useful surgical techniques in anterior segment surgery. Annual meeting of the American Academy of Ophthalmology November 13, 2007, New Orleans, LA.
        3. Instructor: Corneal surgery with the IntraLase femtosecond laser. Annual meeting of the American Academy of Ophthalmology November 13, 2007, New Orleans, LA.
        4. Instructor: Endothelial transplantation: Technique and results. ESCRS. September 9, 2007.  Stockholm, Sweden.
        5. Director.  Big bubble wet lab.  Argentinean Congress of Ophthalmology.  July 17, 2007.  Buenos Aires, Argentina.  
        6. Instructor.  Tophat-shaped femtosecond laser-enabled keratoplasty.  American Society of Cataract and Refractive Surgery, April 28, 2007; San Diego CA.
        7. Instructor: Endothelial keratoplasty: surgical techniques.  April 29, 2007.  American Society of Cataract and Refractive Surgery, April 28, 2007; San Diego CA.
        8. Instructor: Endothelial keratoplasty: prevention and management of donor dislocations.  American Society of Cataract and Refractive Surgery, April 28, 2007; San Diego CA.
        9. Panelist: Keratoconus.  April 30, 2007.  American Society of Cataract and Refractive Surgery, April 28, 2007; San Diego CA.
        10. Instructor:  Advances in anterior segment surgery: Descemet’s stripping endothelial keratoplasty.  Army Medical Department and Walter Reed Postgraduate Course.  March 20, 2007. 
          Bethesda, MD.   
        11. Instructor:  Femtosecond laser-assisted keratoplasty.  Army Medical Department and Walter Reed Postgraduate Course.  March 20, 2007.  Bethesda, MD.
        12. Instructor:  Posterior lamellar keratoplasty and descemet membrane transplantation.  American Academy of Ophthalmology annual meeting.  November 12, 2006. Las Vegas, NV
        13. Instructor:  Femtosecond-enabled keratoplasty: Tophat.  November 12, 2006  American Academy of Ophthalmology annual meeting.  November 12, 2006. Las Vegas, NV
        14. Instructor: Corneal surgery with the IntraLase femtosecond laser.  September 9, 2007.  XXIV Congress of the European Society of Cataract & Refractive Surgeons, London, England.            
        15. Instructor/faculty various courses, conferences 2003-2005.
        16. Faculty: Indiana University in-service. Conductive Keratoplasty. 5/21/03
        17. Faculty:  LASIK. American Academy of Ophthalmology Annual Meeting, Orlando, FL, 10/22/02
        18. Co-Director:  “Comprehensive LASIK Course” Skills Transfer Program – American Academy of Ophthalmology Annual Meeting, Orlando, FL  10/21/02
        19. Course Director:  ­Instructional Course on the AquaFlow® implant.  Price Vision Group, Indianapolis, IN.  May 15, 2002
        20. Course Director: LASIK Skills Transfer Program –American Academy of Ophthalmology Annual Meeting, New Orleans, LA, November 12, 2001
        21. Course Director: Lamellar refractive surgery with a microkeratome. Skills Transfer Program .  American Academy of Ophthalmology Annual Meeting, Dallas, TX, October 23, 2000
        22. Faculty. Lamellar refractive surgery with a microkeratome. American Academy of Ophthalmology Annual Meeting, Orlando, FL  10/25/99
        23. Co-Director: Lamellar refractive surgery with a microkeratome.  Skills Transfer Program - American Academy of Ophthalmology Annual Meeting, Orlando, FL  10/25/99
        24. Faculty.  Lamellar Refractive Surgery with a Microkeratome.  American Academy of Ophthalmology Annual Meeting, New Orleans, LA 11/10/98
        25. Instructor/Surgeon: Santo Domingo live surgery with ICL implants for myopia by STAAR Surgical Corp.  March 25- 28, 1998.
        26. Course Director and Surgeon:  Instructional course on the implantation of a STAAR glaucoma drainage device Corneal Consultants of Indiana, Indianapolis, IN January 30-February 1, 1998
        27. Faculty:  Lamellar refractive surgery with a microkeratome.  American Academy of Ophthalmology Annual Meeting, San Francisco, CA,  October 26-27, 1997
        28. Course Director: Instructional course on incisional and laser refractive surgery for the ophthalmology residents of the Indiana University School of Medicine.  Corneal Consultants of Indiana, Indianapolis, IN  November 16, 1996
        29. Course Director: Instructional course on incisional keratorefractive surgery for the ophthalmology residents of the Indiana University School of Medicine.  Corneal Consultants of Indiana, Indianapolis, IN  November 18, 1995
        30. Panelist:  Paper presentations - Symposium on cataract, IOL, and refractive surgery  ASCRS/ASOA Symposium on Cataract, IOL and Refractive Surgery, San Diego, CA  April 4, 1995
        31. Faculty: Medical management of refractive surgery patients (from which material was used to create a continuing medical education home-study course for physicians)  Sponsored by Education Design, Inc. and Allergan, San Diego, CA  March 31, 1995
        32. Course Director: Instructional course on incisional  keratorefractive surgery for the ophthalmology residents of the Indiana University School of Medicine.  Corneal Consultants of Indiana, Indianapolis, IN  April 23, 1994
        33. Course Director: Instructional course on automated lamellar keratomileusis for corneal surgeons.  Indiana Microsurgical, Indianapolis, IN, September 29, 1993
        34. Course Director: An Instructional Course on Incisional Keratorefractive Surgery.  Cornea Research Foundation of America, Indianapolis, IN, August 28, 1993.
        35. Course Director:  Instructional Course on Radial Keratotomy.  Cornea Research Foundation of America, Indianapolis, IN, March 6, 1993.
        36. Instructor:  Didactic - Surgical Correction of Astigmatism. American Academy of Ophthalmology, Dallas, TX, November 11, 1992
        37. Course Director:  Fall Seminar - Systemic Approach to Ocular Therapeutics, Management of Radial Keratotomy & Surgical Management of Glaucoma.  Cornea Research Foundation of America, Indianapolis, IN,  October 30, 1992
        38. Instructor:  Didactic - Surgical Correction of Astigmatism.  American Academy of Ophthalmology, Anaheim, CA, October 16, 1991
        39. Course Director: Suture‑Fixating Posterior Chamber Intraocular Lenses.  Cornea Research Foundation of America, Indianapolis, IN, April 28, 1991
        40. Co‑Instructor: Didactic ‑ Microsurgical Correction of Astigmatism.  American Academy of Ophthalmology, Atlanta, GA, October 30, 1990
        41. Instructor:  Didactic ‑ Surgical Correction of Astigmatism.  American Academy of Ophthalmology, New Orleans, LA, October 30, 1989
        42. Course Director: Refractive Surgery Introduction and Workshop. Community Hospital of Indianapolis, Indianapolis, Indiana.  1985
        43. Course Director: Refractive Surgery Introduction and Workshop.  Community Hospital of Indianapolis, Indianapolis, Indiana. 1984
        44. Faculty: Vitrectomy for the Anterior Segment Surgeon.  Community Hospital of Indianapolis & Indiana University School of Medicine, Indianapolis, Indiana.  1984
        45. Course Director. Introduction to the Operating Microscope and Ophthalmic Microsurgery.  Community Hospital of Indiana, Indianapolis, Indiana. 1983  
        46. Faculty. A New Orleans Course for Practical Anterior Segment Laser Therapy.  New Orleans, Louisiana.  1982

        Ethics Course
        WIRB Ethics Course, Chicago, Illinois, 8/31/01 (attended).

        Fellowship Director

        1989-Present – Fellowship Director – Post Graduate Studies in Cornea and Refractive Surgery.  Price Vision Group, Indianapolis, IN.

        Hospital Staff Privileges:
        Community Hospitals of Indianapolis
        1500 North Ritter Avenue
        Indianapolis, Indiana 46219

        St. Vincent Hospital and Health Center
        2001 West 86th Street
        Indianapolis, Indiana 46240

        Surgery Center Privileges:
        Naab Road Surgery Center
        8260 Naab Road
        Indianapolis, IN 46260

        Central Indiana Surgery Center
        9002 North Meridian Street, Lower Level
        Indianapolis, Indiana 46260

        Scripting and Co-production of the first commercially available interactive computer programs for Patient Education and Informed Consent in refractive surgery.
        (RK)         Radial Keratotomy
                         1995 - copyright - Price Hall Welch, Inc.

         (PRK)      Photorefractive Keratectomy
                        1995 - copyright - Price Hall Welch, Inc.

        (LASIK)  Laser-assisted in situ Keratomileusis
                        1995 - copyright - Price Hall Welch, Inc.

        (LK)        Lamellar Keratoplasty (keratomileusis in situ)
                        1996 - copyright - Price Hall Welch, Inc.

        Authored an I.D.E. clinical protocol, approved by the FDA, to study "A phase III prospective randomized controlled clinical trial to investigate the simultaneous versus sequential surgical correction of myopia and astigmatism with laser in situ keratomileusis". 

        Authored an I.D.E. clinical protocol, approved by the FDA, to study "A phase III prospective randomized controlled clinical trial to investigate the use versus non use of topical corticosteroids on the stability of the manifest refraction between one and three months after the surgical correction of myopia and astigmatism with laser in situ keratomileusis". 

        Authored an I.D.E. clinical protocol, approved by the FDA, to study “A phase III prospective controlled clinical trial to investigate the ability to decrease the rate of over correction without increasing the rate of retreatment due to under correction with laser in situ keratomileusis”.

        Patents:
        Posterior Chamber Intraocular Lens     
        Serial #846,705   
        Filed March 31, 1986                  
        Patent #4750904

        Eye Filtration Prostheses           
        Serial #07/744,875           
        Filed August 14, 1991        

        Mexican Patent #92-7288
        Filed December 15, 1992

        Corneal Punching System
        Filed October 15, 1993
        Patent #5,334.213

        Corneal Implants and Methods of Use
        Filed April 18, 2005

        Patent Pending